ARCHIVES

No Benefit For Cetuximab In Early-Stage Colon Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

House Approves NCI’s First $4 Billion Budget, $22.8 Billion For NIH In FY2002.

October 26, 2001

Senate Approves $47 Million For More AIDs Drugs

September 19, 1986

UPCI Puts the Cancer Letter on its Intranet for Employees

May 5, 2000

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994